Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Measuring T-cell responses against LCV and CMV in cynomolgus macaques using ELISPOT: potential application to non-clinical testing of immunomodulatory therapeutics.

Kamperschroer C, O'Donnell LM, Schneider PA, Li D, Roy M, Coskran TM, Kawabata TT.

J Immunotoxicol. 2014 Jan-Mar;11(1):35-43. doi: 10.3109/1547691X.2013.766287. Epub 2013 Mar 6.

PMID:
23461640
2.

Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.

Tischer S, Dieks D, Sukdolak C, Bunse C, Figueiredo C, Immenschuh S, Borchers S, Stripecke R, Maecker-Kolhoff B, Blasczyk R, Eiz-Vesper B.

J Immunol Methods. 2014 Jun;408:101-13. doi: 10.1016/j.jim.2014.05.011. Epub 2014 May 28.

PMID:
24877879
4.

Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants.

Abate D, Saldan A, Forner G, Tinto D, Bianchin A, Palù G.

J Virol Methods. 2014 Feb;196:157-62. doi: 10.1016/j.jviromet.2013.10.036. Epub 2013 Nov 8.

PMID:
24216234
5.

An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.

Barabas S, Spindler T, Kiener R, Tonar C, Lugner T, Batzilla J, Bendfeldt H, Rascle A, Asbach B, Wagner R, Deml L.

BMC Immunol. 2017 Mar 7;18(1):14. doi: 10.1186/s12865-017-0195-y.

6.

Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linked immunospot assay.

Calarota SA, Chiesa A, Zelini P, Comolli G, Minoli L, Baldanti F.

Immunology. 2013 Aug;139(4):533-44. doi: 10.1111/imm.12106.

7.

Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients.

Abate D, Saldan A, Mengoli C, Fiscon M, Silvestre C, Fallico L, Peracchi M, Furian L, Cusinato R, Bonfante L, Rossi B, Marchini F, Sgarabotto D, Rigotti P, Palù G.

J Clin Microbiol. 2013 Aug;51(8):2501-7. doi: 10.1128/JCM.00563-13. Epub 2013 May 15. Erratum in: J Clin Microbiol. 2014 Mar;52(3):1025.

8.

Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation.

Merindol N, Salem Fourati I, Brito RM, Grenier AJ, Charrier E, Cordeiro P, Caty M, Mezziani S, Malette B, Duval M, Alfieri C, Ovetchkine P, Le Deist F, Soudeyns H.

J Immunol. 2012 Nov 15;189(10):5016-28. doi: 10.4049/jimmunol.1201759. Epub 2012 Oct 3.

9.

Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge.

Sashihara J, Hoshino Y, Bowman JJ, Krogmann T, Burbelo PD, Coffield VM, Kamrud K, Cohen JI.

PLoS Pathog. 2011 Oct;7(10):e1002308. doi: 10.1371/journal.ppat.1002308. Epub 2011 Oct 20.

10.

High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.

Nickel P, Bold G, Presber F, Biti D, Babel N, Kreutzer S, Pratschke J, Schönemann C, Kern F, Volk HD, Reinke P.

Transpl Immunol. 2009 Mar;20(4):238-42. doi: 10.1016/j.trim.2008.11.002. Epub 2008 Nov 24.

PMID:
19032982
11.

Quantitative PCR assays reveal high prevalence of lymphocryptovirus as well as lytic phase gene expression in peripheral blood cells of cynomolgus macaques.

Kamperschroer C, Tartaro K, Kumpf SW.

J Virol Methods. 2014 Oct;207:220-5. doi: 10.1016/j.jviromet.2014.07.015. Epub 2014 Jul 24.

PMID:
25064358
13.

CTL ELISPOT assay.

Ranieri E, Popescu I, Gigante M.

Methods Mol Biol. 2014;1186:75-86. doi: 10.1007/978-1-4939-1158-5_6.

PMID:
25149304
15.

Monitoring of peptide-specific and gamma interferon-productive T cells in patients with active and convalescent tuberculosis using an enzyme-linked immunosorbent spot assay.

Yang FF, Tu ZQ, Fang YM, Li Y, Peng Y, Dong T, Wang C, Lin SX, Zhan NY, Ma ZM, Feng YZ, Tan SY, Lai XM.

Clin Vaccine Immunol. 2012 Mar;19(3):401-10. doi: 10.1128/CVI.05544-11. Epub 2012 Jan 11.

16.

Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host.

Rivailler P, Carville A, Kaur A, Rao P, Quink C, Kutok JL, Westmoreland S, Klumpp S, Simon M, Aster JC, Wang F.

Blood. 2004 Sep 1;104(5):1482-9. Epub 2004 May 18.

17.

The effect of apoptotic cells on virus-specific immune responses detected using IFN-gamma ELISPOT.

Lenders K, Ogunjimi B, Beutels P, Hens N, Van Damme P, Berneman ZN, Van Tendeloo VF, Smits EL.

J Immunol Methods. 2010 May 31;357(1-2):51-4. doi: 10.1016/j.jim.2010.03.001. Epub 2010 Mar 6.

PMID:
20214906
18.
19.
20.

Optimization of an elispot assay to detect cytomegalovirus-specific CD8+ T lymphocytes.

Godard B, Gazagne A, Gey A, Baptiste M, Vingert B, Pegaz-Fiornet B, Strompf L, Fridman WH, Glotz D, Tartour E.

Hum Immunol. 2004 Nov;65(11):1307-18.

PMID:
15556681

Supplemental Content

Support Center